The missing voice of patients in drug-safety reporting

Affiliations

Ethan Basch. N Engl J Med. 2010.

. 2010 Mar 11;362(10):865-9.

doi: 10.1056/NEJMp0911494.

No abstract available

Comment in

Outcomes research: Integrating PROs into the clinic - overall survival benefit or not, it's worth the trouble.
Sperti E, Di Maio M. Sperti E, et al. Nat Rev Clin Oncol. 2017 Sep;14(9):529-530. doi: 10.1038/nrclinonc.2017.109. Epub 2017 Jul 18. Nat Rev Clin Oncol. 2017. PMID: 28719587 No abstract available.

1. Pakhomov SV, Jacobsen SJ, Chute CG, Roger VL. Agreement between patient-reported symptoms and their documentation in the medical record. Am J Manag Care. 2008;14(8):530–9. - PMC - PubMed
1. Weingart SN, Gandhi TK, Seger AC, et al. Patient-reported medication symptoms in primary care. Arch Intern Med. 2005;165(2):234–40. - PubMed
1. Basch E, Jia X, Heller G, et al. Adverse symptom reporting by patients versus clinicians: relationships with clinical outcomes. J Nat Cancer Inst. 2009;101(23):1624–1632. - PMC - PubMed
1. Institute of Medicine, National Academy of Sciences. The Future of Drug Safety: Promoting and Protecting the Health of the Public. National Academies Press; Washington, DC: 2006.
1. Ioannidis JP, Evans SJ, Gøtzsche PC, O’Neill RT, Altman DG, Schulz K, Moher D. CONSORT Group. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med. 2004 Nov 16;141(10):781–8. - PubMed